- We think Valens is one of few Canadian cannabis stocks worth considering at current prices; our bullish call in February was followed by an almost 100% share price appreciation.
- The stock is no longer dirt cheap but remains significantly cheaper than peers; however, we are now Neutral given reduced upside potential.
- Given the current margin profile and uncertainty around the U.S. CBD market, Valens shares are reasonably valued with potential catalysts that require further execution and evidence.
For further details see:
Valens Company: Time To Take Profits After 100% Rally